Xiangyong Kong

机构：University of Science and Technology of China

发表论文 3 篇

代表论文

• Empagliflozin Reduces Post-Myocardial Infarction Inflammation via BDH1/β-Hydroxybutyrate-Mediated NF-κB Modulation in Macrophages and the Heart (2026 · Journal of Cardiovascular Pharmacology)
• Prognostic value of resting high-frequency QRS for clinical outcomes after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: A prospective cohort study (2026 · Asian Heart Journal)
• Exercise high-frequency QRS versus exercise stress electrocardiography in diagnosing myocardial ischemia: A meta-analysis (2026 · Journal of Electrocardiology)